Home Page - 2026 Miami GU Oncology Summit

The 2026 Miami GU Oncology Summit is an annual, clinically focused conference dedicated to advancing the diagnosis and management of genitourinary (GU) cancers, including prostate, bladder, kidney, and testicular malignancies. This educational meeting brings together leading experts and healthcare professionals to review the latest clinical evidence, treatment innovations, and multidisciplinary care strategies in GU oncology.

The summit will feature a robust program of expert-led didactic sessions, multidisciplinary panel discussions, and interactive case-based learning designed to enhance clinical decision-making and improve patient outcomes. Participants will gain insights into emerging therapies, precision oncology, immunotherapy, and evolving standards of care, with a focus on translating research into real-world practice.

Key topics will include risk stratification, biomarker-driven treatment selection, management of advanced and metastatic disease, treatment sequencing, and survivorship care. Case-based sessions will highlight complex and controversial scenarios, enabling participants to apply evidence-based approaches in diverse clinical settings.

This conference emphasizes practical, patient-centered care and interdisciplinary collaboration, equipping clinicians with the knowledge and tools needed to optimize outcomes for patients with GU malignancies.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Hyatt Regency Miami